RAPT Therapeutics
RAPT
RAPT
98 hedge funds and large institutions have $637M invested in RAPT Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less funds holding
Funds holding: 106 → 98 (-8)
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
Holders
98
Holding in Top 10
5
Calls
$10.8M
Puts
$108K
Top Buyers
| 1 | +$18.4M | |
| 2 | +$8.1M | |
| 3 | +$6.83M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.21M |
| 5 |
EC
Euclidean Capital
New York
|
+$2.59M |
Top Sellers
| 1 | -$6.08M | |
| 2 | -$5.98M | |
| 3 | -$4.96M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$4.79M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.5M |